Author

Joseph E. Spahr

Observed names: J. E. Spahr, Joseph E Spahr, Joseph Spahr

Observed institutions: University of Utah, Huntsman Cancer Institute

OpenAlex ID: A5073363116

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

2019 · Luis Paz-Ares, Mikhail Dvorkin, et al. · The Lancet · 2,281

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

2020 · Jonathan W Goldman, Mikhail Dvorkin, et al. · The Lancet Oncology · 688

Superwarfarin poisoning: A report of two cases and review of the literature

2006 · Joseph E. Spahr, J. Scott Maul, et al. · American Journal of Hematology · 108

Treatment of immune‐mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients

2007 · Joseph E. Spahr, George M. Rodgers · American Journal of Hematology · 82

Acquired amegakaryocytic thrombocytopenic purpura

2006 · Neeraj Agarwal, Joseph E. Spahr, et al. · American Journal of Hematology · 39

Successful management of intra-abdominal hemorrhage in the presence of severe alcoholic liver disease with activated recombinant factor VII (rFVIIa; NovoSeven): a case report and review of the literature on approved and off-label use of rFVIIa

2007 · Neeraj Agarwal, Joseph E Spahr, et al. · Blood Coagulation & Fibrinolysis · 9

Cancer survival: Which low molecular weight heparin (LMWH) is best?

2007 · J. E. Spahr, W. Akerley, et al. · Journal of Clinical Oncology

Treatment of Immune-Mediated Thrombocytopenia Purpura with Concurrent IVIg and Platelet Transfusion: A Retrospective Review of 40 Patients.

2006 · Joseph E. Spahr, Neeraj Agarwal, et al. · Blood

Works count: 8

Citation count: 3,204

H-index: 6

I10-index: 5